An Insight into the Effect of Schiff Base and their d and f Block Metal Complexes on Various Cancer Cell Lines as

Presenjit1,2, Shubhra Chaturvedi1, Akanksha Singh3

  • 1Radiological Nuclear and Imaging Sciences, Institute of Nuclear Medicine & Allied Sciences, DRDO, Timarpur, 110054, Delhi, India.

Insights

Schiff bases and their metal complexes show promise as novel anticancer agents. These compounds can overcome multidrug resistance and enhance chemotherapy efficacy, offering new hope for cancer treatment.

Area of Science:

  • Bioinorganic Chemistry
  • Medicinal Chemistry
  • Oncology

Background:

  • Rising cancer incidence and multidrug resistance necessitate novel therapeutic strategies.
  • Existing treatments face challenges due to widespread drug resistance.
  • Metallo-drugs and small molecules offer potential but require optimization.

Purpose of the Study:

  • To explore Schiff bases and their d and f block metal complexes as anticancer agents.
  • To review the potential of these compounds in overcoming multidrug resistance.
  • To highlight their role in enhancing current cancer treatment modalities.

Main Methods:

  • Review of existing literature on Schiff bases and their metal complexes.
  • Analysis of their chemical structures and biological properties.
  • Evaluation of their anticancer efficacy against various cancer cell lines.

Main Results:

  • Schiff bases exhibit adaptable metal chelating abilities and tunable structures.
  • Their complexes demonstrate significant anticancer activity.
  • They show potential in overcoming multidrug resistance and enhancing chemotherapy.

Conclusions:

  • Schiff bases and their metal complexes are promising candidates for novel anticancer drugs.
  • They offer multifaceted therapeutic benefits, including apoptosis induction and angiogenesis inhibition.
  • Further development is warranted to create effective, side-effect-free cancer treatments.

Related Concept Videos

Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...